Clinical Trials Logo

Clinical Trial Summary

The investigators objective is to compare OASIS wound matrix with other commonly used dressings available for the donor site in split thickness skin grafting in order to determine which dressing provides the best outcome based on pain level, time to healing and aesthetic outcome.


Clinical Trial Description

Investigators seek to compare Oasis wound matrix with Tegaderm and Xeroform in order to determine whether advantages exist in one or more of the dressing types that are approved and currently used for split-thickness skin graft donor site dressings.

Patients will be randomly assigned to one of the three treatment groups and followed up post-operatively and treated as per current standard of care.

Data to be collected and analyzed includes: patient age, co-morbid illnesses, medication, skin-graft donor location, skin-graft donor area, STSG thickness, infection rate, complications involving the donor site, post-operative pain score every morning until hospital discharge, healing rate, photographs of the donor site immediately post-operatively and then at routine follow-up appointments. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02994589
Study type Interventional
Source Loma Linda University
Contact
Status Withdrawn
Phase Phase 4
Start date October 2016
Completion date December 2016

See also
  Status Clinical Trial Phase
Recruiting NCT03937765 - The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites N/A
Terminated NCT04014400 - Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites N/A
Recruiting NCT04648267 - Factors Affecting Split Thickness Skin Graft Success Rates in Patients Who Underwent a Radial Forearm or Fibula Free Flap N/A
Withdrawn NCT03548610 - Efficacy and Safety of a Nanofat-seeded Biological Scaffold in Healing Lower Limb Surgical Defects N/A
Completed NCT04231305 - Antithrombotics and Complications in Skin Grafts
Recruiting NCT04186273 - Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. Phase 2